🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.

Recruitingn/aAges 7 Years - 25 YearsAllCentre Hospitalier Universitaire de Saint Etienne
NCT07117058 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In France today, it is estimated that one in every 850 people aged between 20 and 45 is a childhood cancer survivor (CCS), equivalent to around 40,000 to 50,000 people. Some descriptive studies have established that the diagnosis and treatment of cancer can affect psychological health. A French study published by our team in 2015 and 2020 showed that in adulthood, 40% of CCS had anxiety symptoms, a rate significantly higher than that of the general French population (25%). However, although there are validated scales for screening children for psychological disorders (anxiety, depression, etc.), there is no rapid screening tool that can be used routinely by an oncologist during consultations. So, the study aims to develop and validate a short test, which could easily be carried out systematically during follow-up consultations after childhood cancer. It would make it possible to identify

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria * Patients diagnosed with pediatric cancer before the age of 18, * Patient whose intensive treatment had ended at least 3 months prior to inclusion, * Patients considered to be in complete remission by the doctor responsible for their treatment, * Patient affiliated to or entitled under a social security scheme, * Patient having received informed information about the study OR the holder(s) of parental authority having received informed information about the study in the case of minors. Exclusion Criteria * Refusal to participate expressed by the patient or minor, * Patients whose cancer has relapsed or progressed, * Pregnant women, women in labor, breast-feeding mothers, * Persons deprived of their liberty, hospitalized without consent, hospitalized for purposes other than those of the research, * Adults under legal protection (guardianship) or unable to express their consent.
💊

What it tests

  • New rapid screening tool for anxiety and depressive disorders
  • SCARED-R-51 (Screen for Child Anxiety Related Emotional Disorders-Revised)
  • HADS (Hospital Anxiety and Depression Scale)
📍

Where

7 sites
CHU Angers
Angers, France
Centre Hospitalier Universitaire Caen Normandie
Caen, France
Centre Hospitalier Universitaire
Grenoble, France
IHOPe
Lyon, France
CENTRE HOSPITALIER UNIVERSAIRE DE NICE - Hôpital Archet 2
Nice, France
Centre Hospitalier Universitaire
Rouen, France
CHU de Saint-Etienne
Saint-Etienne, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy